These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy. Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729 [TBL] [Abstract][Full Text] [Related]
4. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399 [TBL] [Abstract][Full Text] [Related]
5. Curcumin-coordinated nanoparticles with improved stability for reactive oxygen species-responsive drug delivery in lung cancer therapy. Luo CQ; Xing L; Cui PF; Qiao JB; He YJ; Chen BA; Jin L; Jiang HL Int J Nanomedicine; 2017; 12():855-869. PubMed ID: 28182160 [TBL] [Abstract][Full Text] [Related]
6. Curcumin and Paclitaxel Co-loaded Heparin and Poloxamer P403 Hybrid Nanocarrier for Improved Synergistic Efficacy in Breast Cancer. Nguyen NT; Bui QA; Huynh PD; Nguyen QH; Tran NQ; Viet NT; Nguyen DT Curr Drug Deliv; 2022 Aug; 19(9):966-979. PubMed ID: 35366771 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers. Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422 [TBL] [Abstract][Full Text] [Related]
8. Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A). Khan MN; Haggag YA; Lane ME; McCarron PA; Tambuwala MM Curr Drug Deliv; 2018 Feb; 15(2):286-295. PubMed ID: 29065834 [TBL] [Abstract][Full Text] [Related]
9. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Ruttala HB; Ko YT Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481 [TBL] [Abstract][Full Text] [Related]
10. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509 [TBL] [Abstract][Full Text] [Related]
11. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585 [TBL] [Abstract][Full Text] [Related]
12. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line. Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970 [TBL] [Abstract][Full Text] [Related]
13. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin. Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101 [TBL] [Abstract][Full Text] [Related]
14. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration. Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302 [TBL] [Abstract][Full Text] [Related]
15. Efficient Codelivery of Paclitaxel and Curcumin by Novel Bottlebrush Copolymer-based Micelles. Yao Q; Gutierrez DC; Hoang NH; Kim D; Wang R; Hobbs C; Zhu L Mol Pharm; 2017 Jul; 14(7):2378-2389. PubMed ID: 28605595 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment. Amornwachirabodee K; Chiablaem K; Wacharasindhu S; Lirdprapamongkol K; Svasti J; Vchirawongkwin V; Wanichwecharungruang SP J Pharm Sci; 2012 Oct; 101(10):3779-86. PubMed ID: 22806358 [TBL] [Abstract][Full Text] [Related]
17. Cell Permeating Nano-Complexes of Amphiphilic Polyelectrolytes Enhance Solubility, Stability, and Anti-Cancer Efficacy of Curcumin. Fatima MT; Chanchal A; Yavvari PS; Bhagat SD; Gujrati M; Mishra RK; Srivastava A Biomacromolecules; 2016 Jul; 17(7):2375-83. PubMed ID: 27192144 [TBL] [Abstract][Full Text] [Related]
18. Combined Delivery and Anti-Cancer Activity of Paclitaxel and Curcumin Using Polymeric Micelles. Gao X; Wang B; Wu Q; Wei X; Zheng F; Men K; Shi H; Huang N; Wei Y; Gong C J Biomed Nanotechnol; 2015 Apr; 11(4):578-89. PubMed ID: 26310065 [TBL] [Abstract][Full Text] [Related]
19. Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells. Manju S; Sreenivasan K Langmuir; 2011 Dec; 27(23):14489-96. PubMed ID: 21988497 [TBL] [Abstract][Full Text] [Related]
20. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells. Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]